Ocular findings by CDG due to the SRD5A3 gene variant have been reported by microphthalmia, cataract, chorioretinal coloboma, glaucoma, optic nerve hypoplasia/atrophy, and nystagmus [26,29]. This evidence concerns the gene SRD5A3 and glaucoma.